Delta, Kelowna, BC – September 16, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts #605, Cannabis News and Stocks on the Move; (CSE: XTRX), (TSX: HEXO) (NASDAQ: HEXO), (NASDAQ: SNDL) (TSX-V: ENTG)
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com “Potcast” featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
HEXO Corp (TSX: HEXO) (NASDAQ: HEXO) today announced the Company had achieved its goal to become carbon neutral by September 2021, offsetting 100% of its 2020 operational carbon emissions in addition to the personal emissions of its 1,200 employees.
In June of 2021, HEXO embarked on a mission to counteract its carbon footprint, through a partnership with Offsetters, a Vancouver-based organization that supports renewable energy and forest carbon projects across the world. As a leading cannabis player in Canada, on the path to becoming one of the top three global cannabis products companies, it was important for HEXO’s offset investments to have a global reach. At home in Canada, HEXO is helping reduce old-growth tree harvesting by supporting the Great Bear Forest Carbon Project. This landmark project balances human well-being and ecological integrity through carbon finance and is the first carbon project in North America on traditional territory with unextinguished Aboriginal rights and title. Globally, HEXO is supporting two other carbon offset projects – a large-scale solar energy project in Asia and another forest conservation project in South America.
To achieve carbon neutrality, HEXO offset a total of 25,965 tonnes of carbon – 19,610 tonnes of operational carbon emissions and 6,355 tonnes of their employee’s personal carbon emissions. If the top 100 Canadian companies pursued similar sustainability initiatives, it would be a significant contribution to Canada’s role in combating climate change.
“At the start of the summer, we pledged that HEXO would not only become carbon neutral, but that we would also offset the personal carbon emissions generated by every one of our employees. Today we are proud to say we have achieved our goal, setting a new standard in sustainability for our industry,” said HEXO Corp. CEO and Co-founder, Sebastien St-Louis. “Consumers and investors demand greater environmental and social integrity from companies. We are proud to share our commitment to sustainability and support our consumers’ ability to purchase products that align with their values.”
In addition to carbon emissions, HEXO is counteracting the use of plastic in its packaging. Working alongside their primary packaging supplier Dymapak, in conjunction with Plastic Bank(R), HEXO has supported Plastic Bank’s ethical recycling ecosystems in coastal communities, collecting and reprocessing ocean-bound plastics for re-introduction to the global manufacturing supply chain. In doing so, HEXO initially offset 63,000 kilograms of plastic. By October 2021, HEXO will have supported the collection of an additional 8,000 kg of ocean-bound plastic – making it a total equivalent of over 3.55 million plastic bottles stopped from entering the world’s oceans.
In supporting environmentalism, HEXO will continue to monitor and report on its carbon emissions and plastic production and seek opportunities to reduce both. HEXO plans to emulate its success in the Canadian cannabis industry throughout the United States.
HEXO is committed to continuously improving its Environmental, Social and Governance strategy which focuses on people, planet and product. For more information on these efforts and how the Company continues to develop its stakeholder relations to make a positive contribution to communities globally, please visit: https://www.forwardstartsatneutral.com/.
Sundial Growers Inc. (NASDAQ: SNDL), a Canadian licensed producer that crafts premium cannabis, has launched Caviar Cones, its newest product innovation, under the award-winning Top Leaf brand. The Forbidden Lemon Caviar Cones will be the first caviar cone product to hit the Canadian market. This launch reinforces Sundial’s focused innovation pipeline around premium inhalables in the Canadian cannabis market.
“Top Leaf’s brand promise is to deliver top quality inhalable products to consumers in the premium cannabis segment,” said Andrew Stordeur, President and Chief Operating Officer at Sundial. “In order to compete in this preferred segment of the cannabis industry, product quality is absolutely vital. Top Leaf’s Caviar Cones is the first of many high quality, high THC and flavourful products developed to satisfy even the most experienced cannabis user.”
The launch of Caviar Cones is not only a milestone for Sundial, but also represents the first product of its kind to launch in the Canadian cannabis market at large. Infused products have done exceptionally well in the American market according to recent sales data from Headset, a leading provider of data and analytics to the cannabis industry. Headset has deemed “connoisseur infused” products – which includes caviar cones – as a segment to watch as it has risen from approximately 13% to 32% of all cone-type products in 2021 year to date in the United States.
The Top Leaf Caviar Cones are a carefully handcrafted, individually inspected blend of dried milled flower, dry sift hash and full spectrum winterized oil resulting in a smooth smoke with a unique flavour experience, exceptional terpene profile and guaranteed THC of 30% or higher. Sundial’s approach involves infusing processed whole flower with both hash and oil extract to ensure an even distribution throughout the entire caviar cone for an exceptional terpene profile and high levels of THC. The Forbidden Lemon strain mixes the terpene-heavy Forbidos, the uplifting Blue Dream, and the fresh Lemon Haze and Florida Lemon strains. Additional strains will be available for consumers later this year. Top Leaf Caviar Cones are available in a 4 x 0.5 gram rolled multipack.
Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF), a Canadian producer and distributor of award-winning cannabis products and brands, announced the Canadian launch of acclaimed Mary’s Medicinals Transdermal Patches.
Mary’s Medicinals is part of the Mary’s Brands (“Mary’s”) portfolio and a BellRock Brands Inc. company. As the exclusive manufacturer and licensed distributor for Mary’s suite of products in Canada, Entourage launches Mary’s Transdermal Patches in CBD, THC and 1:1 formulations that will be available first to the Company’s Starseed Medicinal patients as of late September 2021. Products are expected to expand into the adult-use retail market later this year.
Mary’s Transdermal Patches – when applied as a skin adhesive – could act as a novel and discreet delivery method containing a THC, CBD and/or balanced 1:1 dosed formula and are made with ingredients which are known to promote transdermal* effects (absorption into body through the skin).
“With the launch of Mary’s Transdermal Patches, we are taking a major step forward in offering our clients with unique cannabis delivery methods for their self-care journey – and more critically, could offer an alternative to debilitating opioid use with a portfolio of safe and regulated cannabis delivery systems,” said Joseph Mele, Senior Vice President, Commercial, Sales & Marketing. “Our roots in medical run deep and we are fully committed to the continued expansion of our medical portfolio that now includes over 40 SKUs of innovative products developed alongside forward-thinking partners that allow us to cater to a wider range of consumers seeking a discreet interface for cannabis consumption.”
Entourage is producing Mary’s Medicinals Canada products in-house at its Aylmer, Ontario-based extraction hub, using its own input biomass. The Company’s product development and extraction teams are using Mary’s proprietary technology which calls for extracting CBD, THC and CBN – the active cannabinoid ingredients used to produce topical compounds and formulas for its award-winning balms and patches.
With the expansion of Mary’s product suite, the Company’s medical channel, Starseed continues to gather important insights, data and client feedback. Starseed’s eligible patients with benefits coverage may be able to purchase Mary’s products with insured benefits.
Adastra Holdings Ltd. (formerly Phyto Extractions Inc.) (CSE: XTRX) announced that it has entered into a share purchase agreement dated September 15, 2021 pursuant to which the Company has agreed to acquire all the issued and outstanding shares of 1204581 B.C. Ltd., doing business as Phyto Extractions from the shareholders of Phyto Extractions.
Phyto Extractions, the best-known brand in Canadian cannabis concentrates, was incorporated in 2019 in the Province of British Columbia and is engaged in the marketing and promotion of cannabis concentrate products in Canada under the Cannabis Regulations. Phyto Extractions licenses its intellectual property to Canadian cannabis license holders and collects royalties generated by selling cannabis consumer packaged goods to provincial distributors and retailers across the country. From July 1, 2020, to June 30, 2021, Phyto Extractions branded products generated unaudited royalty payments totaling $1.82 million. Post-closing, Adastra intends to leverage Phyto Extraction’s valuable suite of branded products to drive sales and integration efficiencies. Phyto Extractions is being acquired with minimal long-term debt and positive working capital.
Michael Forbes, Chief Executive Officer of Adastra stated, “We are excited at the prospect of bringing the most prominent legacy brand into Adastra. We believe the proposed acquisition of Phyto Extractions will add tremendous shareholder value. Phyto Extractions currently holds a preeminent place in the regulated cannabis concentrates market owing to unparalleled brand recognition, quality products, market penetration, and exceptional sales team. As licensing agreements expire, Adastra intends to produce all Phyto Extractions products in-house and recognize full revenues resulting from branded sales.”
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also available on iTunes (Apple Podcasts), Audible, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.
About Investorideas.com – News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns: Crypto Corner, Play by Play sports and stock news, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast, Cleantech and Climate Change, Exploring Mining, Betting on Gaming Stocks Podcast and the AI Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android